This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Keytruda
  • /
  • A Study of Pembrolizumab (MK-3475) for First Line ...
Clinical trial

A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)

Read time: 3 mins
Last updated:19th Mar 2015
Identifier: NCT02358031
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest